The article Veterans at Forefront of the Psychedelic Medicine Movement was originally published on Microdose. United States special operations forces...
The drug development company has launched a Community Stakeholder Initiative that allows more people to invest in next-generation empathogens. The post...
During this edition of the Investor Hotseat, host Dustin Robinson of Iter Investments is joined by Greg Mayes of Reunion Neuroscience. Greg currently leads...
A business founded by researchers at Kennesaw State University to improve the process of growing specialty mushrooms won the People’s Choice Award and...
The article 2023 Starts With Psychedelic Decrim Measures In Several States was originally published on Microdose. 2023 has started off as a good year...
The therapeutic benefits of psychedelic medicines may not require the psychoactive effects. The post To Trip or Not to Trip? Why Non-Hallucinogenic Treatments...
Cybin (NYSE American: CYBN | NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(R). The company today announced...
Field Trip Health & Wellness Ltd. (TSX-V: FTHW), a global leader in the delivery of psychedelic therapies, today launched Field Trip Online Therapy,...
The article Cybin Selects Generalized Anxiety Disorder for DMT Drug CYB-004 was originally published on Microdose. Cybin has selected Generalized Anxiety...
Modern psychiatry and research did not "discover" psychedelics for mental health. The post How Indigenous Knowledge About Psychedelic Plants Can Shape...
Researchers in Japan have generated a high-quality genome assembly of red perilla (Perilla frutescens), a plant most often found in Asia and commonly known...
The Daily Hit is a recap of cannabis business news for Jan. 11, 2023. ON THE SITE Connecticut Recreational Cannabis Sales Top $250,000 on Day One...
The article Enthea Offers Access to Psychedelic Therapy With Health Insurance Plans was originally published on Microdose. Access. After all the drug...
Source: Spyro the Dragon/Shutterstock.com Fans of Jaguar Health (NASDAQ:JAGX) stock will want to keep an eye on the company tomorrow as it prepares for...
The article Algernon Pharmaceuticals Announces Plans for 180 Patient Phase 2b Study was originally published on Microdose. Algernon continues to move...